TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

5.07
Delayed Data
As of Feb 27
 -0.27 / -5.06%
Today’s Change
3.42
Today|||52-Week Range
9.01
+13.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues48.2K2.1M3.8M8.8M
 
 
 
 
 
Cost of Goods Sold71.9K947.1K1.3M2.0M
 
 
 
 
 
Depreciation And Amortization61.4K54.8K56.3K58.1K
 
 
 
 
 
 
Operating ExpensesGross Income-85.1K1.1M2.4M6.8M
 
 
 
 
 
General Expenses382.9K6.5M18.6M32.8M
 
 
 
 
 
Research And Development--107.2K4.5M13.6M
 
 
 
 
Total Operating Expenses516.2K7.5M20.0M34.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-468.0K-5.4M-16.1M-26.1M
 
 
 
 
 
Extraordinary Credit0.000.000.00250.0K
 
 
Extraordinary Charge0.00-7.4M-17.0M0.00
 
 
 
Interest Expense On Debt64.1K64.4K2.0M2.7M
 
 
 
 
 
Other Expenses22.1K-31.8K3.0K34.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-509.9K-12.9M-35.1M-28.4M
 
 
 
 
 
Discontinued Operations-445.2K0.000.000.00
 
 
Extraordinary Items259.7K0.000.000.00
 
 
Net Income-955.1K-12.9M-35.1M-28.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS164.2K62.5M91.6M127.6M
 
 
 
 
 
Shares To Calculate EPS Diluted164.2K62.5M91.6M127.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.00-$0.21-$0.38-$0.22
 
 
 
 
 
EPS Diluted-$6.00-$0.21-$0.38-$0.22
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account